Načítá se...
Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck
LESSONS LEARNED. Chemotherapy for recurrent, metastatic squamous cell carcinoma of the head and neck need not be known for extreme toxicity. The weekly regimen studied here has been demonstrated to be tolerable and effective. BACKGROUND. The objective of this study was to establish the response rate...
Uloženo v:
| Vydáno v: | Oncologist |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AlphaMed Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058339/ https://ncbi.nlm.nih.gov/pubmed/29540603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0618 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|